Lord's Mark Industries Reports H1'27 Results and Strategic Expansion
Lords Mark Industries Ltd · Others (Uncategorized) · 15 Nov 2026, 4:28 am
Lord's Mark Industries Reports H1'27 Results and Strategic Expansion Lord's Mark Industries released revised results for the half-year ended 30th Sep'26. Consolidated revenue reached ₹71,876.76 lakh with EBITDA of ₹13,151 lakh (18.30% margin), PBT of ₹11,254.33 lakh, and PAT of ₹8,200.86 lakh (11.41% margin). Standalone H1 revenue stood at ₹65,530.62 lakh with PAT at ₹7,956.22 lakh. Key growth drivers include securing 26 additional medical device licenses, commencing AI dialysis machine production in Bangalore with global exports starting late Dec'26, expanding US/UK subsidiaries, advancing CAR-T therapy trials, and constructing a third IVD manufacturing facility operational before Mar'28.
Original exchange filing (PDF)
More announcements from Lords Mark Industries Ltd
- Investor Presentation H1 · 18 Nov 2026
- Investor Meet on 19th Nov 2026 · 16 Nov 2026
- Revised financials for September 2026 · 15 Nov 2026
- Outcome of Board Meeting held on 14.11.2026 · 14 Nov 2026
- September 2026 results · 14 Nov 2026
- Lords Mark Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2026 ,inter alia, to consider and approve Board Meeting intimation .... · 14 Nov 2026
- Dr. Sachidanand Upadhyay , MD has featured in TIME magazine for third consecutive years . · 03 Nov 2026
- Regulation 30 intimation · 30 Oct 2026
